The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells
M Kim(University of Alabama at Birmingham), Joanne T. Douglas(Gene Therapy Laboratory), L A Sumerel(University of Alabama at Birmingham), Brian Barnett(University of Alabama at Birmingham), Victor Krasnykh(University of Alabama at Birmingham), Kurt R. Zinn(University of Alabama at Birmingham), David T. Curiel(University of Alabama at Birmingham)
Cited by 137
Related Papers
An Adenovirus Vector with Genetically Modified Fibers Demonstrates Expanded Tropism via Utilization of a Coxsackievirus and Adenovirus Receptor-Independent Cell Entry Mechanism
|Journal of Virology|1998|769
Engineering targeted viral vectors for gene therapy
|Nature Reviews Genetics|2007|678
Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function
|The Journal of Immunology|2006|487
Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer
|Clinical Cancer Research|2015|477